BAA says shift responsibility for oversight of the National Medicines Policy

Vertex has welcomed confirmation the PBAC will consider cystic fibrosis therapy TRIKAFTA at its December meeting for all 2,000 eligible patients.

A new report suggests almost 120,000 Australians are still living with hepatitis C more than five years after the first direct-acting antiviral cures were reimbursed through the PBS.

GSK's Christi Kelsey says the company will launch its third Reconciliation Action Plan (RAP) a decade after starting its own journey.

"With so many talented local researchers, we are proud to support initiatives like this which help to invigorate the local research eco-system,” said AbbVie's Chris Stemple.

According to Bloomberg, the number of COVID-19 vaccines administered globally is 6.88 billion across 184 countries. The latest daily rate of doses administered is 32 million. COVAX has so far shipped over 378 million doses of COVID-19 vaccines to 144 participants.

Nicole Cooper has used her submission to the National Medicines Policy review to argue any update should not just reflect changes that have already occurred but look to the future and prioritise patient need.

The federal government will spend almost $100 million on adding new screening tests for parents undertaking IVF but only because MSAC said it will avoid births and the need to pay for treatment.

MSD says patients will be hoping for a positive reimbursement outcome after the TGA added another indication to the company's immuno-oncology therapy KEYTRUDA (pembrolizumab).

Health minister Greg Hunt has announced expanded access to Lilly's breast cancer therapy VERZENIO (abemaciclib).

How is the shameful treatment of one patient any worse than a paid alliance of groups promoting cheaper alternatives to patients under the absurd Orwellian guise of ‘optimising’ the use of more expensive treatments?

MSAC will consider the potential adoption of lung cancer screening almost three years after the federal government commissioned Cancer Australia to develop a report that found strongly in favour of its potential to save lives.

A group of companies will come together today for the first meeting of the Reconciliation Action Plan Health Industry Network.

New South Wales says it will "lead Australia with a first-of-its-kind pilot facility" to develop mRNA and RNA medicines and vaccines.

The contract implementing the 'Value in Prescribing' savings measure shows the Department of Health requires the consortium to promote non-bDMARD treatments directly to consumers to support its target of generating $50 million in savings.

Rebates paid by companies under product-specific risk-share arrangements hit a record level last year, according to the Department of Health's 2020-21 annual report.

Documents obtained by BioPharmaDispatch reveal how the Department of Health divided over $3.5 million between the groups contracted to deliver the so-called 'Value in Prescribing' budgeted savings measure.

Sanofi Pasteur has launched a new multi-year campaign it says is designed to support conversations about the value and importance of vaccines.

An updated report from Healthy Bones Australia has found that only one-in-two adults who have broken a bone reported having a bone mineral density test.

Dr Kathryn Evans, the area director of BioMarin Australia and New Zealand, on how organisations need to get serious about gender by closing the leadership and pay gaps.